Arcadia Biosciences CEO Matthew Plavan's 2020 pay jumps 37% to $794K
Arcadia Biosciences reports 2020 executive compensation
By ExecPay News
Published: April 20, 2021
Arcadia Biosciences reported fiscal year 2020 executive compensation information on April 20, 2021.
In 2020, four executives at Arcadia Biosciences received on average a compensation package of $549K, a 23% increase compared to previous year.
Average pay of disclosed executives at Arcadia Biosciences
Matthew Plavan, Chief Executive Officer, received $794K in total, which increased by 37% compared to 2019. 47% of Plavan's compensation, or $370K, was in salary. Plavan also received $99K in non-equity incentive plan and $326K in option awards.
Sarah Reiter, Former Chief Commercial Officer, received a compensation package of $527K, which increased by 16% compared to previous year. 41% of the compensation package, or $214K, was in option awards.
Pamela Haley, Chief Financial Officer, earned $443K in 2020, a 55% increase compared to previous year.
Randall Shultz, Chief Technology Officer, received $431K in 2020, which increases by 27% compared to 2019.
Related executives
You may also like
Source: SEC filing on April 20, 2021.